Bleakley Financial Group LLC bought a new position in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 5,825 shares ...
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been assigned an average recommendation of “Buy” from the seven research firms that are covering the stock, Marketbeat.com reports. One ...
Barclays analyst Balaji Prasad maintained a Buy rating on Zoetis (ZTS – Research Report) today and set a price target of $242.00. The company’s ...
What is a better day than Valentine’s Day to remember and celebrate the great love stories our world has witnessed? From the ...
My mind doesn’t work like everyone else’s. That’s no surprise to those of you who know me. I won’t go so far as to say my mind is twisted, but I see things a little ...
Highlights,Janney Montgomery Scott LLC reduced its stake in Tarsus Pharmaceuticals by 10.5%.,Institutional and hedge funds ...
After hours: February 7 at 6:45:52 PM EST Loading Chart for TARS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results